# Anthony D. Ho

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anthony-d-ho/

## Facts

| Field | Value |
| --- | --- |
| Citations | 43,398 |
| Field | Hematopoietic Stem Cell Transplantation |
| h-index | 96 |
| i10-index | 518 |
| Last Known Institution | Heidelberg University |
| OpenAlex ID | https://openalex.org/A5067574718 |
| ORCID iD | https://orcid.org/0000-0002-1656-0833 |
| Works | 1,156 |

## Researcher papers

- [Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.](https://scholariq.org/papers/rituximab-chimeric-anti-cd20-monoclonal-antibody-therapy-for-relapsed-indolent/)

## Researcher topics

- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [Heidelberg University](https://scholariq.org/institutions/heidelberg-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.